A surge in demand for hormone replacement therapy (HRT) has led to shortages of estrogen patches, affecting women managing perimenopause and menopause symptoms. Since 2021, HRT usage among women has increased by 72%, resulting in supply chain disruptions. The FDA’s removal of certain boxed warnings has contributed to this rise in prescriptions. Experts recommend discussing alternative forms of estradiol with healthcare providers during the shortage, as some women adapt to brand-name treatments that can be costly and less accessible.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
